Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

RAPT Therapeutics, Inc. Common Stock (RAPT)

Pharmaceutical Preparations

https://www.rapt.com

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

561 ECCLES AVENUE
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/01/2019

Market Cap

76,438,665

Shares Outstanding

34,400,000

Weighted SO

34,396,212

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

CNTB --.--%

TYRA --.--%

XLO --.--%

MLYS --.--%

MOLN --.--%

ANTX --.--%

PHVS --.--%

PEPG --.--%

GLUE --.--%

Beta

0.3580

Last Div

0.0000

Range

2.12-27.35

Chg

-0.0700

Avg Vol

457970

Mkt Cap

76438665

Exch

NASDAQ

Country

US

Phone

650 489 9000

DCF Diff

1.1417

DCF

1.0583

Div Yield

0.0000

P/S

14.4551

EV Multiple

-0.3521

P/FV

0.7793

Div Yield %

0.0000

P/E

-0.7068

PEG

0.0336

Payout

0.0000

Current Ratio

8.1411

Quick Ratio

8.1411

Cash Ratio

2.5050

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

535.8595

CCC

-535.8595

Gross Margin

0.6502

Op Margin

-24.3918

Pretax Margin

-22.7744

Net Margin

-22.7744

Eff Tax Rate

-0.0235

ROA

-0.9469

ROE

-0.8604

ROCE

-1.1478

NI/EBT

1.0000

EBT/EBIT

0.9337

EBIT/Rev

-24.3918

Debt Ratio

0.0450

D/E

0.0524

LT Debt/Cap

0.0281

Total Debt/Cap

0.0498

Int Coverage

-56.3003

CF/Debt

-18.3126

Equity Multi

1.1644

Rec Turnover

0.0000

Pay Turnover

0.6811

Inv Turnover

0.0000

FA Turnover

0.8478

Asset Turnover

0.0416

OCF/Share

-2.6983

FCF/Share

-2.7044

Cash/Share

2.9547

OCF/Sales

-19.8328

FCF/OCF

1.0023

CF Coverage

-18.3126

ST Coverage

-40.8396

CapEx Coverage

-442.5148

Div&CapEx Cov

-442.5148

P/BV

0.7793

P/B

0.7793

P/S

14.4551

P/E

-0.7068

P/FCF

-0.7272

P/OCF

-0.8116

P/CF

-0.8116

PEG

0.0336

P/S

14.4551

EV Multiple

-0.3521

P/FV

0.7793

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation